Haleon (NYSE:HLN) Receives New Coverage from Analysts at Berenberg Bank

Investment analysts at Berenberg Bank assumed coverage on shares of Haleon (NYSE:HLNGet Free Report) in a research report issued to clients and investors on Wednesday, Briefing.com reports. The firm set a “buy” rating on the stock.

A number of other research analysts have also weighed in on the company. Argus reaffirmed a “buy” rating on shares of Haleon in a report on Tuesday, March 26th. HSBC started coverage on Haleon in a report on Wednesday, April 17th. They set a “buy” rating for the company. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, Haleon currently has a consensus rating of “Moderate Buy”.

Read Our Latest Analysis on HLN

Haleon Stock Down 1.1 %

HLN stock opened at $8.38 on Wednesday. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $38.26 billion, a PE ratio of 27.93, a PEG ratio of 2.25 and a beta of 0.26. Haleon has a twelve month low of $7.70 and a twelve month high of $8.96. The stock has a 50-day simple moving average of $8.33 and a two-hundred day simple moving average of $8.33.

Haleon (NYSE:HLNGet Free Report) last posted its earnings results on Wednesday, May 1st. The company reported $0.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.01. The business had revenue of $3.70 billion during the quarter, compared to analyst estimates of $3.71 billion. Haleon had a return on equity of 13.17% and a net margin of 9.68%. On average, equities analysts predict that Haleon will post 0.46 EPS for the current fiscal year.

Institutional Trading of Haleon

A number of large investors have recently modified their holdings of HLN. Hexagon Capital Partners LLC lifted its position in Haleon by 107.3% in the 4th quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company’s stock worth $35,000 after buying an additional 2,193 shares during the last quarter. Pinnacle Bancorp Inc. lifted its position in Haleon by 853.4% in the 4th quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company’s stock worth $39,000 after buying an additional 4,267 shares during the last quarter. Allspring Global Investments Holdings LLC bought a new stake in Haleon in the 1st quarter worth approximately $43,000. Tower Research Capital LLC TRC lifted its position in Haleon by 146.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,398 shares of the company’s stock worth $44,000 after buying an additional 3,211 shares during the last quarter. Finally, SRS Capital Advisors Inc. lifted its position in Haleon by 456.4% in the 4th quarter. SRS Capital Advisors Inc. now owns 5,458 shares of the company’s stock worth $45,000 after buying an additional 4,477 shares during the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Company Profile

(Get Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

See Also

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.